Associated Papers
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors.
Poveda A et al.
Scientific Reports, 2021
33627685 (PubMed )
Supplement: 41598_2021_82671_MOESM1_ESM.pdf
Select a paper to view details